BIOMAT Database Logo BIOMAT Database Logo

Syntheses and antitumor activities of 7-O-(3-amino-2,3,6-trideoxy-2-fluoro-alpha-L-talopyranosyl)daunomvcinone and -adriamycinone. 1989

Y Takagi, and H Park, and T Tsuchiya, and S Umezawa, and T Takeuchi, and K Komuro, and C Nosaka
Institute of Bioorganic Chemistry, Kanagawa, Japan.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Y Takagi, and H Park, and T Tsuchiya, and S Umezawa, and T Takeuchi, and K Komuro, and C Nosaka
Syntheses and antitumor activities of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
May 1986, The Journal of antibiotics,
Y Takagi, and H Park, and T Tsuchiya, and S Umezawa, and T Takeuchi, and K Komuro, and C Nosaka
Syntheses and antitumor activities of 7-O-(6-deoxy-2-O-methyl-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
August 1989, The Journal of antibiotics,
Y Takagi, and H Park, and T Tsuchiya, and S Umezawa, and T Takeuchi, and K Komuro, and C Nosaka
Synthesis and antitumor activities of 14-O-acyl derivatives of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)adriamycinone.
July 1988, The Journal of antibiotics,
Y Takagi, and H Park, and T Tsuchiya, and S Umezawa, and T Takeuchi, and K Komuro, and C Nosaka
Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
November 1987, Carbohydrate research,
Y Takagi, and H Park, and T Tsuchiya, and S Umezawa, and T Takeuchi, and K Komuro, and C Nosaka
Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
March 1999, Carbohydrate research,
Y Takagi, and H Park, and T Tsuchiya, and S Umezawa, and T Takeuchi, and K Komuro, and C Nosaka
Design, synthesis and biological activity of 7-O-(4-O-acetyl-3-iodo-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl) daunomycinone and 7-O-(3-chloro-2,3,6-trideoxy-4-O-propanoyl-alpha-L-lyxo- hexopyranosyl)daunomycinone.
January 2000, Chemical & pharmaceutical bulletin,
Y Takagi, and H Park, and T Tsuchiya, and S Umezawa, and T Takeuchi, and K Komuro, and C Nosaka
Synthesis of 7-O-[2,6-dideoxy-2-fluoro-4-O-(3-fluorotetrahydropyran-2-yl)- alpha-L-talopyranosyl]daunomycinone.
March 1992, The Journal of antibiotics,
Y Takagi, and H Park, and T Tsuchiya, and S Umezawa, and T Takeuchi, and K Komuro, and C Nosaka
Synthesis of 3-amino-2,3,6-trideoxy-2-fluoro-L-talose and -D-allose [(R)-2-fluoro-L-daunosamine and (R)-2-fluoro-D-ristosamine].
January 1990, Carbohydrate research,
Y Takagi, and H Park, and T Tsuchiya, and S Umezawa, and T Takeuchi, and K Komuro, and C Nosaka
7-O-(3-Amino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)daunomycinone, a configurational analog of daunorubicin.
November 1979, Carbohydrate research,
Y Takagi, and H Park, and T Tsuchiya, and S Umezawa, and T Takeuchi, and K Komuro, and C Nosaka
Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
February 1998, Carbohydrate research,
Copied contents to your clipboard!